Drugs that contain Bupivacaine

1. List of Exparel drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11278494 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11179336 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11426348 PACIRA PHARMS INC Compositions of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11452691 PACIRA PHARMS INC Compositions of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11357727 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11311486 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11304904 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

US11033495 PACIRA PHARMS INC Manufacturing of bupivacaine multivesicular liposomes
Jan, 2041

(17 years from now)

Exclusivity Exclusivity Expiration
New Patient Population (NPP) Mar 22, 2024

Market Authorisation Date: 28 October, 2011

Treatment: Method of treating pain, for example, treating postsurgical pain via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia; Method of treating pain, for example, via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia; Method of treating pain, for example, via infiltration for local analgesia or via nerve block, for example, nterscalene brachial plexus for regional analgesia; Method of providing local or regional analgesia via infiltration for local analgesia or via interscalene brachial plexus nerve block or femoral nerve block for regional analgesia; Method of providing postsurgical pain management, for example, via infiltration for local analgesia or via interscalene brachial plexus nerve block for regional analgesia

Dosage: INJECTABLE, LIPOSOMAL;INJECTION

How can I launch a generic of EXPAREL before it's patent expiration?
More Information on Dosage

EXPAREL family patents

12

United States

1

United Kingdom

1

China

1

European Union

2. List of Posimir drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8846072 DURECT Controlled delivery system
Sep, 2025

(2 years from now)

US8153149 DURECT Controlled delivery system
Sep, 2025

(2 years from now)

US8153661 DURECT Controlled delivery system
Sep, 2025

(2 years from now)

US8753665 DURECT Controlled delivery system
Sep, 2025

(2 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Feb 1, 2024

Market Authorisation Date: 01 February, 2021

Treatment: Method for providing sustained local anesthesia for at least 24 hours

Dosage: SOLUTION, EXTENDED RELEASE;INFILTRATION

More Information on Dosage

POSIMIR family patents

14

United States

4

European Union

3

Portugal

3

Spain

3

Cyprus

3

Slovenia

3

Poland

3

Denmark

2

Korea, Republic of

2

EA

2

Japan

1

Russia

1

Brazil

1

Croatia

1

New Zealand

1

Norway

1

Mexico

1

Austria

1

China

1

Hong Kong

1

South Africa

1

Lithuania

1

Canada

1

Hungary

1

Ukraine

1

Israel

1

Georgia

1

Australia

1

RS

3. List of Posimir drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11400019 INNOCOLL Sustained release drug delivery systems with reduced impurities and related methods
Jan, 2041

(17 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Feb 1, 2024

Market Authorisation Date: 01 February, 2021

Treatment: NA

Dosage: SOLUTION, EXTENDED RELEASE;INFILTRATION

More Information on Dosage

POSIMIR family patents

4

United States

1

Korea, Republic of

1

Canada

1

Brazil

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic